Date |
|
Jun 11, 2021 |
CEL-SCI Announces the Closing of $31.7 Million Bought Deal Offering |
Jun 8, 2021 |
CEL-SCI Increases Previously Announced Bought Deal to $31.7 Million |
Jun 8, 2021 |
CEL-SCI Announces Bought Deal Offering |
May 18, 2021 |
CEL-SCI Corporation Reports Second Quarter Fiscal 2021 Financial Results |
Feb 16, 2021 |
CEL-SCI Corporation Reports First Quarter Fiscal 2021 Financial Results |
Jan 8, 2021 |
CEL-SCI Corporation to Present at the 2021 H.C. Wainwright BIOCONNECT Virtual Conference |
Jan 4, 2021 |
CEL-SCI Corporation Issues Letter to Shareholders |
Dec 30, 2020 |
CEL-SCI Reports Fiscal 2020 Financial Results and Clinical & Corporate Developments |
Dec 14, 2020 |
CEL-SCI Corporation to Present at the 13th Annual LD Micro Main Event Conference |
Dec 11, 2020 |
CEL-SCI Announces the Closing of Its $14.65 Million Bought Deal |